Concepedia

Richard B. Wilber

RB

23

Publications

4.4K

Citations

18

H-Index

1980

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

University of Santo Tomas

National Cheng Kung University

University of Michigan

Richard B. Wilber is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and pharmacokinetics.

Top concepts

Publications per year

1980–2009

23

Publications

23

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

Ting‐Tsung Chang, Robert G. Gish, Robert de Man et al. · New England Journal of Medicine · 2006 · 1.4K citations · Full text

Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

Ching‐Lung Lai, Daniel Shouval, Anna S. Lok et al. · New England Journal of Medicine · 2006 · 1.2K citations · Full text

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy #

Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick et al. · Hepatology · 2009 · 810 citations · Full text

Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures

Margaret Johnson, Beatriz Grinsztejn, Claudia Rodríguez et al. · AIDS · 2005 · 249 citations

Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B

Nancy Leung, Hie‐Won Hann, Jose D. Sollano et al. · Hepatology · 2008 · 181 citations · Full text

Rows per page

1–5 of 23